Chronic neutropenia: how best to assess severity and approach management?
Jean DonadieuStephanie FrenzLauren MerzFlore Sicre De FontbruneGioacchino Andrea RotuloBlandine BeaupainMartin Biosse-DuplanMarie AudrainLaure CroisillePhil AncliffChristoph KleinChristine Bellanné-ChantelotPublished in: Expert review of hematology (2021)
In most cases, the neutropenia is transient, frequently related to a viral infection, and not harmful. However, neutropenia can be chronic (i.e. >3 months) and related to a number of etiologies, some clinically benign, such as so-called 'ethnic' neutropenia. Autoimmune neutropenia is the common form in young children, whereas idiopathic/immune neutropenia is a frequent etiology in young females. Inherited neutropenia (or congenital neutropenia) is exceptional, with approximately 30 new cases per 106 births and 30 known subtypes. Such patients have a high risk of invasive bacterial infections, and oral infections. Supportive therapy, which is primarily based on daily administration of an antibiotic prophylaxis and/or treatment with granulocyte-colony stimulating factor (G-CSF), contributes to avoiding recurrent infections.